capecitabine has been researched along with Incontinentia Pigmenti Achromians in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alonso, V; Calduch, L; Jordá, E; Martín, JM; Pinazo, MI; Villalón, G | 1 |
| Hymes, SR; Paravar, T | 1 |
2 other study(ies) available for capecitabine and Incontinentia Pigmenti Achromians
| Article | Year |
|---|---|
Focal acral hyperpigmentation in a patient undergoing chemotherapy with capecitabine.
Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Deoxycytidine; Dermoscopy; Female; Fluorouracil; Foot Dermatoses; Hand Dermatoses; Humans; Middle Aged; Pigmentation Disorders; Tongue Diseases | 2009 |
Longitudinal melanonychia induced by capecitabine.
Topics: Adult; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Female; Fluorouracil; Humans; Nail Diseases; Pigmentation Disorders | 2009 |